Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Calabrese

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Archives of Internal Medicine|July 1, 1980
Familial late complement component (C6, C7) deficiency with chronic meningococcemiaJ D Clough, M L Clough, A Weinstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 1, 1986
Immune reactivity in Bell's palsyG B Hughes, B P Barna, S E Kinney, et al.
AIDS Research|January 1, 1984
Serum beta 2-microglobulin and interferon in homosexual males: relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III)L H Calabrese, M R Proffitt, M K Gupta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Arthritis and Rheumatism|August 1, 1984
T cell lymphoma occurring in Sjögren's syndromeW S Wilke, R R Tubbs, R M Bukowski, et al.
JAMA|February 6, 1987
Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factorJ T Carey, M M Lederman, Z Toossi, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestationsD Vassilopoulos, Z M Younossi, E Hadziyannis, et al.
Cleveland Clinic Journal of Medicine|November 1, 1992
Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence areaJ Smucny, D Hom, J J Ellner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.
Cleveland Clinic Quarterly|January 1, 1986
Epidemiologic and laboratory evaluation of homosexual males from an area of low incidence for acquired immunodeficiency syndrome (AIDS)L H Calabrese, M R Proffitt, L Bocci, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Archives of Internal Medicine|July 1, 1980
Familial late complement component (C6, C7) deficiency with chronic meningococcemiaJ D Clough, M L Clough, A Weinstein, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|December 1, 1986
Immune reactivity in Bell's palsyG B Hughes, B P Barna, S E Kinney, et al.
AIDS Research|January 1, 1984
Serum beta 2-microglobulin and interferon in homosexual males: relationship to clinical findings and serologic status to the human T lymphotropic virus (HTLV-III)L H Calabrese, M R Proffitt, M K Gupta, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 16, 2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors)K L Winthrop, X Mariette, J T Silva, et al.
Arthritis and Rheumatism|August 1, 1984
T cell lymphoma occurring in Sjögren's syndromeW S Wilke, R R Tubbs, R M Bukowski, et al.
JAMA|February 6, 1987
Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factorJ T Carey, M M Lederman, Z Toossi, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestationsD Vassilopoulos, Z M Younossi, E Hadziyannis, et al.
Cleveland Clinic Journal of Medicine|November 1, 1992
Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence areaJ Smucny, D Hom, J J Ellner, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.
Cleveland Clinic Quarterly|January 1, 1986
Epidemiologic and laboratory evaluation of homosexual males from an area of low incidence for acquired immunodeficiency syndrome (AIDS)L H Calabrese, M R Proffitt, L Bocci, et al.
Pageof 17